Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Advances in qPCR and dPCR

Arndt Schmitz's Biography



Arndt Schmitz, Head/Senior Scientist, Bayer Schering Pharma AG

Dr. Arndt Schmitz is Head of Research Biobank at Bayer pharma’s Global Drug Discovery unit. He obtained a diploma in chemistry, and, subsequently, his PhD in biochemistry from the Biocenter of Basel University. As a post-doc at Cold Spring Harbor Laboratory in the US he continued work on signal transduction. Dr Schmitz then joined Schering AG (Berlin, Germany) as a biotechnology group leader. Today, besides running the Research Biobank, he is taking care of biomarker aspects of therapeutics projects. His activities focus on Drug Discovery and Development, in particular the implementation of emerging technologies in clinical trials.

Arndt Schmitz Image

Analysing Circulating Tumor DNA in Clinical Trials – Today and in Future

Thursday, 15 May 2014 at 17:00

Add to Calendar ▼2014-05-15 17:00:002014-05-15 18:00:00Europe/LondonAnalysing Circulating Tumor DNA in Clinical Trials – Today and in FutureAdvances in qPCR and dPCR in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com

BAYER experiences with analysing 2,000 samples in our clinical trials with the most sensitive technique available will be reported. The field will soon be more complex, with established techniques becoming companion diagnostics and new technologies such as NGS entering.


Add to Calendar ▼2014-05-14 00:00:002014-05-15 00:00:00Europe/LondonAdvances in qPCR and dPCRAdvances in qPCR and dPCR in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com